Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|April 1, 1999
Supplements and Featured Publications
- Use of Selective Estrogen Receptor Modulators among Postmenopausal Women in the Managed Care Setting
- Volume 5
- Issue 3 Suppl
Bibliography
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
An Introduction to SERMS and Their Gynecologic Effectsover 27 years ago
Cardiovascular Effects of Selective Estrogen Receptor Modulatorsover 27 years ago
Selective Estrogens and Breast Tissueover 27 years ago
Discussionover 27 years ago
Selected Abstractsover 27 years ago
CME Quizover 27 years ago
Skeletal Effects of Selective Estrogen Receptor ModulatorsAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5